Landscape Capital Management’s West Pharmaceutical WST Stock Holding History

Landscape Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.35M	Sell	12,112 -2,317	-16%	-$708K	0.28%	84
2026 Q1	$3.62M	Buy	14,429 +7,998	+124%	+$1.99M	0.23%	137
2025 Q4	$1.77M	Buy	+6,431	New	+$1.76M	0.12%	264
2023 Q2	–	Sell	-1,773	Closed	-$614K	–	717
2023 Q1	$614K	Buy	+1,773	New	+$518K	0.08%	186
2019 Q3	–	Sell	-2,861	Closed	-$358K	–	834
2019 Q2	$358K	Hold	2,861	–	–	0.03%	491
2019 Q1	$315K	Sell	2,861 -151	-5%	-$15.7K	0.03%	521
2018 Q4	$295K	Buy	+3,012	New	+$327K	0.02%	653

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Landscape Capital Management's WST Position: Q2 2026 in Review

Landscape Capital Management reduced its West Pharmaceutical (WST) stake by 16% in Q2 2026, selling an estimated $708K and leaving 12,112 shares worth $4.35M. The position accounts for 0.28% of the portfolio, ranked #84.

Landscape Capital Management first reported a position in WST in Q4 2018 and has held it in 7 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Landscape Capital Management held 12,112 shares of West Pharmaceutical worth $4.35M as of Q2 2026.
Landscape Capital Management sold 2,317 West Pharmaceutical shares in Q2 2026, an estimated $708K.
West Pharmaceutical made up 0.28% of Landscape Capital Management's portfolio in Q2 2026, its #84 holding.
Landscape Capital Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 7 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.